Literature DB >> 25727133

Subjective ratings of neurocognitive functioning in depressed young people undergoing treatment: utility of a brief screening tool.

Caroline A Fisher1, Joanne Goodall2, Magenta B Simmons2,3, Kelly Allott2, Sarah E Hetrick2,3.   

Abstract

AIMS: To determine how young people with depression rate their neurocognitive functioning during treatment, and whether these ratings are affected by depression severity, age, suicidal ideation and antidepressant status.
METHODS: Fifty young people (12-25 years) engaged in psychological therapy completed the Neuropsychological Symptoms Self-Report rating their neurocognitive functioning in a range of domains.
RESULTS: In two domains, working memory/multitasking and motivation, more than 40% of the sample rated their functioning as improved, since commencing treatment. Ratings of neurocognitive functioning were affected by depression severity and suicidal ideation, particularly in the areas of wakefulness, attention and concentration, working memory/multitasking, and motivation. However, there were few differences related to age or antidepressant status.
CONCLUSIONS: The Neuropsychological Symptoms Self-Report - a rapid measure of subjective neurocognitive functioning - can provide a snapshot of subjective changes in neurocognitive functioning during treatment for depression. This information may guide treatment approaches.
© 2015 Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  adolescent; depression; neurocognitive; neuropsychology; self-report; young adult

Mesh:

Substances:

Year:  2015        PMID: 25727133     DOI: 10.1111/eip.12226

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  1 in total

1.  Subjective experiences of neurocognitive functioning in young people with major depression.

Authors:  Catherine Morey-Nase; Lisa J Phillips; Shayden Bryce; Sarah Hetrick; Andrea L Wright; Emma Caruana; Kelly Allott
Journal:  BMC Psychiatry       Date:  2019-07-04       Impact factor: 3.630

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.